Market Place
Sourcing Support
All News #Library
Biotech
Xenon Pharma Discloses Inducement Grants Per Nasdaq LR 5635(C)(4)
01 May 2026 //
GLOBENEWSWIRE
Xenon To Present At Upcoming Investor Conferences
15 Apr 2026 //
GLOBENEWSWIRE
Xenon Shares Phase 3 X-TOLE2 and Azetukalner Data
07 Apr 2026 //
GLOBENEWSWIRE
Xenon Seeks FDA Approval for Epilepsy Drug After Phase 3 Win
10 Mar 2026 //
BIOSPACE
Xenon Reports Q4 and Full Year 2025 Financial Results and Update
26 Feb 2026 //
GLOBENEWSWIRE
Xenon Highlights 2026 Milestones At J.P. Morgan Health Conference
12 Jan 2026 //
GLOBENEWSWIRE
Xenon To Present At J.P. Morgan Healthcare Conference
05 Jan 2026 //
GLOBENEWSWIRE
Xenon Announces Azetukalner Epilepsy Webinar at AES 2025
03 Dec 2025 //
GLOBENEWSWIRE
Xenon To Unveil Azetukalner OLE Study Results In Epilepsy At AES
25 Nov 2025 //
GLOBENEWSWIRE
Xenon To Report Q3 2025 Financial Results On November 3, 2025
27 Oct 2025 //
GLOBENEWSWIRE
Xenon Plans Investor Webinar On Ion Channel Programs For Pain
25 Sep 2025 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.